Zinc Pretreatment Inhibits Isotretinoin Teratogenicity and Induces Embryonic Metallothionein in CD-1 Mice

Manuscript received 13 August 1997. Initial reviews completed 18 December 1997. Revision accepted 11 March 1998.

Danielle Blain^*, Stan Kubow^*, and Hing Man Chan^{*, ,}

^* School of Dietetics and Human Nutrition,  Centre for Indigenous Peoples' Nutrition and Environment, Macdonald Campus of McGill University, Ste. Anne de Bellevue, Quebec, Canada H9X 3V9

Isotretinoin (ITR), a teratogen in many species, is associated with increased oxidative stress. Metallothionein (MT) is an important tissue antioxidant whose concentrations are induced by zinc. To study the role of supplemental Zn as an inducer of embryonic MT, we injected pregnant CD-1 mice subcutaneously with saline vehicle, or 20 or 40 mg/kg Zn on gestational day (GD) 6.5. After 48 h, embryonic MT concentrations increased in a dose-related manner (r = 0.64, P < 0.05) with Zn treatment. The possible protective role of Zn pretreatment against ITR teratogenicity was investigated in vivo and in vitro. CD-1 mice were pretreated with saline or Zn (20 and 40 mg/kg) on GD 8.5 and 9.5. ITR was administered to both groups of mice via three intragastric intubations of 100 mg ITR/kg at 4 h intervals on GD 10.5. On GD 18.5, Zn pre-treated mice demonstrated decreased ITR-mediated growth retardation, cleft palates and postpartum mortality. A reduction in embryonic MT concentrations was observed in mice exposed to ITR. Mouse embryos cultured on GD 8.5 with an addition of 15 µmol/L Zn for 48 h had a sixfold greater MT concentration (688 µg/g protein) than controls. The Zn pretreatment of cultured embryos prevented malformations and lessened growth retardation caused by 24 h exposure to 17 µmol/L ITR. These results suggest that Zn-mediated induction of MT in mouse embryos could protect against ITR teratogenicity.

The Journal of Nutrition Vol. 128 No. 7 July 1998, pp. 1239-1246
Copyright ©1998 by the American Society for Nutritional Sciences

This article has been cited by other articles:

				Q. Sun, R. M. van Dam, W. C. Willett, and F. B. Hu Prospective Study of Zinc Intake and Risk of Type 2 Diabetes in Women Diabetes Care, April 1, 2009; 32(4): 629 - 634. [Abstract] [Full Text] [PDF]

				W. Kennette, O. M. Collins, R. K. Zalups, and J. Koropatnick Basal and Zinc-Induced Metallothionein in Resistance to Cadmium, Cisplatin, Zinc, and tertButyl Hydroperoxide: Studies Using MT Knockout and Antisense-Downregulated MT in Mammalian Cells Toxicol. Sci., December 1, 2005; 88(2): 602 - 613. [Abstract] [Full Text] [PDF]

				S. R. Davis, D. A. Samuelson, and R. J. Cousins Metallothionein Expression Protects against Carbon Tetrachloride-Induced Hepatotoxicity, but Overexpression and Dietary Zinc Supplementation Provide No Further Protection in Metallothionein Transgenic and Knockout Mice J. Nutr., February 1, 2001; 131(2): 215 - 222. [Abstract] [Full Text]